ZYMFENTRA (infliximab-dyyb)

**Product type:** Human Prescription Drug

**Active ingredient:** INFLIXIMAB-DYYB

**Strength:** 120 mg/mL

**Dosage form:** Injection

**Route:** Subcutaneous

**Labeler:** CELLTRION USA Inc.

**Marketing category:** BLA (BLA761358)

**Pharmacologic class:** Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]